| # | Drug | Count |
|---|---|---|
| 0 | ETANERCEPT | 19 |
| 1 | ALENDRONATE SODIUM | 16 |
| 2 | DABIGATRAN ETEXILATE MESYLATE | 15 |
| 3 | METHOTREXATE SODIUM | 15 |
| 4 | ADALIMUMAB | 14 |
| 5 | DENOSUMAB | 14 |
| 6 | GABAPENTIN | 13 |
| 7 | RIVAROXABAN | 13 |
| 8 | ASPIRIN | 12 |
| 9 | DABIGATRAN ETEXILATE | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CASTOR OIL | 1 | 0.0052 |
| 1 | DROSPIRENONE AND ESTETROL | 1 | 0.0034 |
| 2 | ELOSULFASE ALFA | 11 | 0.0020 |
| 3 | SELEGILINE HYDROCHLORIDE | 1 | 0.0017 |
| 4 | CHROMIC CHLORIDE | 1 | 0.0012 |
| 5 | AVALGLUCOSIDASE ALFA-NGPT | 1 | 0.0010 |
| 6 | ELRANATAMAB-BCMM | 1 | 0.0009 |
| 7 | PIOGLITAZONE HYDROCHLORIDE | 1 | 0.0008 |
| 8 | METRELEPTIN | 1 | 0.0008 |
| 9 | AFATINIB | 5 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 42 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 30 |
| 2 | Factor Xa Inhibitor [EPC] | 27 |
| 3 | Corticosteroid [EPC] | 20 |
| 4 | Atypical Antipsychotic [EPC] | 17 |
| 5 | Benzodiazepine [EPC] | 15 |
| 6 | Interleukin-23 Antagonist [EPC] | 15 |
| 7 | Provitamin D2 Compound [EPC] | 15 |
| 8 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 15 |
| 9 | Kinase Inhibitor [EPC] | 14 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 7 | 0.0102 |
| 1 | Endoglycosidase [EPC] | 2 | 0.0011 |
| 2 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 13 | 0.0010 |
| 3 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 1 | 0.0008 |
| 4 | Leptin Analog [EPC] | 1 | 0.0008 |
| 5 | Serotonin and Norepinephrine Reuptake Inhibitor [EPC] | 2 | 0.0005 |
| 6 | Provitamin D2 Compound [EPC] | 15 | 0.0005 |
| 7 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |
| 8 | alpha-Glucosidase Inhibitor [EPC] | 2 | 0.0004 |
| 9 | Catechol-O-Methyltransferase Inhibitor [EPC] | 2 | 0.0004 |